Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

October 24, 2022

Study Completion Date

March 27, 2023

Conditions
Lung NeoplasmsPulmonary Metastasis
Interventions
DEVICE

Pulmonary Radiofrequency Ablation System and the Disposable Pulmonary Radiofrequency Ablation Catheter

The conjunction of the pulmonary RFA system with the disposable pulmonary RFA catheter developed by Hangzhou Broncus Medical Co., Ltd. is aim to specifically target lung tumors. The ablation catheter is designed to reach the tumor through the bronchial pathway.

Trial Locations (3)

100000

The First Hospital of Peking University, Beijing

200000

Shanghai Chest Hospital, Shanghai

510000

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Hangzhou Broncus Medical Co., Ltd.

INDUSTRY

NCT04619472 - Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors | Biotech Hunter | Biotech Hunter